drugset / Trial / NCT06973785

Non-Narcotic Pain Control After ACL Reconstruction

NCT06973785

Phase 3 Active not recruiting 30 enrolled The Cleveland Clinic
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a double-blind randomized controlled trial of standard of care therapy, either oral ketorolac (experimental group) or oral oxycodone (control group) to demonstrate efficacy in reducing the percentage of narcotic doses taken and documenting the number of patients with no exposure to any narcotics (take zero oxycodone) after undergoing primary knee ACL reconstruction outpatient surgery.

Timeline

Start
2025-07-15
Primary completion
2026-06-12
Completion
2027-06-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 10 mg Oral
Comparator Oxycodone Other / unclassified 5 mg Oral
Comparator Acetaminophen Small molecule

Indications

No indication recorded.